Guo Dai

1.2k total citations
34 papers, 932 citations indexed

About

Guo Dai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guo Dai has authored 34 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Guo Dai's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and Developmental Biology and Gene Regulation (3 papers). Guo Dai is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and Developmental Biology and Gene Regulation (3 papers). Guo Dai collaborates with scholars based in China, Ethiopia and United Kingdom. Guo Dai's co-authors include Ling Yu, Sheng Zhou, Shuang Deng, Min Xiong, Hongsong Fang, Sen Chen, Hao Peng, Jianlin Zhou, Zhigang Nie and Zhengpei Zhang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Guo Dai

34 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo Dai China 17 575 336 124 75 69 34 932
Geng Li China 20 707 1.2× 424 1.3× 111 0.9× 53 0.7× 71 1.0× 44 1.0k
Xiaohong Yang China 17 610 1.1× 183 0.5× 247 2.0× 119 1.6× 88 1.3× 56 1.1k
Zhijun Zhao China 17 653 1.1× 370 1.1× 109 0.9× 90 1.2× 83 1.2× 40 962
Ilaria Buondonno Italy 18 464 0.8× 112 0.3× 181 1.5× 124 1.7× 66 1.0× 23 965
Lida Guo United States 17 558 1.0× 105 0.3× 134 1.1× 124 1.7× 42 0.6× 23 1.1k
Wenfeng Li China 13 439 0.8× 231 0.7× 96 0.8× 41 0.5× 62 0.9× 28 670
Thilo S. Lange United States 21 572 1.0× 135 0.4× 149 1.2× 68 0.9× 83 1.2× 38 1.1k
Donghai Xiong United States 19 495 0.9× 216 0.6× 290 2.3× 193 2.6× 138 2.0× 39 987

Countries citing papers authored by Guo Dai

Since Specialization
Citations

This map shows the geographic impact of Guo Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo Dai more than expected).

Fields of papers citing papers by Guo Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo Dai. The network helps show where Guo Dai may publish in the future.

Co-authorship network of co-authors of Guo Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Guo Dai. A scholar is included among the top collaborators of Guo Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo Dai. Guo Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Guo, Xiao‐Jun Huang, Yuze Li, et al.. (2023). Identification of a linear epitope in the capsid protein of goose astrovirus with monoclonal antibody. Polish Journal of Veterinary Sciences. 25(4). 579–587. 3 indexed citations
2.
Liu, Lei, Siwen Chen, Xiang Li, et al.. (2021). BRD4promotes heterotopic ossification through upregulation of LncRNA MANCR. Bone and Joint Research. 10(10). 668–676. 7 indexed citations
3.
Dai, Guo, et al.. (2021). Synergistic Anticancer Effects of Cisplatin Combined with Combretastatin A4 Phosphate on Human Osteosarcoma-Xenografted Mice. Cells Tissues Organs. 210(4). 293–300. 4 indexed citations
4.
Zhang, Shan, et al.. (2021). Middle school students’ alternative conceptions about the human blood circulatory system using four-tier multiple-choice tests. Journal of Biological Education. 57(1). 51–67. 10 indexed citations
6.
Li, Xiang, Siwen Chen, Zaiying Hu, et al.. (2020). Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis. EMBO Molecular Medicine. 12(12). e12109–e12109. 25 indexed citations
7.
Dai, Guo, et al.. (2018). miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Scientific Reports. 8(1). 606–606. 82 indexed citations
8.
Deng, Shuang, Guo Dai, Sen Chen, et al.. (2018). Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomedicine & Pharmacotherapy. 110. 602–608. 180 indexed citations
9.
Dai, Guo, et al.. (2018). Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway. Cellular Physiology and Biochemistry. 46(3). 1134–1147. 39 indexed citations
10.
Zhang, Zhengpei, Ling Yu, Guo Dai, et al.. (2017). Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells. Scientific Reports. 7(1). 7070–7070. 31 indexed citations
11.
Zhou, Sheng, Ling Yu, Min Xiong, & Guo Dai. (2017). LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochemical and Biophysical Research Communications. 495(2). 1822–1832. 111 indexed citations
12.
Guo, Xiaodong, Ling Yu, Zhengpei Zhang, et al.. (2017). miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1. Cancer Cell International. 17(1). 29–29. 36 indexed citations
13.
Jia, Peng, et al.. (2017). Chitosan oligosaccharides protect nucleus pulposus cells from hydrogen peroxide-induced apoptosis in a rat experimental model. Biomedicine & Pharmacotherapy. 93. 807–815. 18 indexed citations
14.
Dai, Guo, Di Zheng, Qianliang Wang, et al.. (2017). Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway. Oncotarget. 8(49). 86098–86116. 31 indexed citations
15.
Yu, Ling, et al.. (2016). Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling. European Journal of Pharmacology. 794. 77–84. 43 indexed citations
16.
Dai, Guo, Qing Xu, Rong Luo, et al.. (2015). Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction. BMC Cardiovascular Disorders. 15(1). 170–170. 18 indexed citations
17.
Ning, Yue, et al.. (2015). Development and characterization of microsatellite loci in Megalonibea fusca. Genetics and Molecular Research. 14(2). 4633–4636. 1 indexed citations
18.
Dai, Guo, et al.. (2015). Isolation and characterization of polymorphic microsatellite loci in the sea cucumber Holothuria scabra. Genetics and Molecular Research. 14(2). 6529–6532. 7 indexed citations
19.
Ning, Yue, et al.. (2015). Short Communication Screening the first set of polymorphic microsatellite loci in Lunella coronata granulata (Turbinidae). Genetics and Molecular Research. 14(2). 6319–6322. 2 indexed citations
20.
Huang, Yan, et al.. (2007). Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells. Journal of Cellular Biochemistry. 103(1). 21–29. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026